Letters to the Editor

Proteomic shifts post plasma cell therapy in AL amyloid plaques and potential implications for light chain directed anti-fibril monoclonal antibodies

Division of Hematology, Mayo Clinic, Rochester, MN
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Proteomics Core, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Nephrology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Haematologica Early view Jul 24, 2025 https://doi.org/10.3324/haematol.2025.288217